• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MERIT MEDICAL SYSTEMS INC. HERO®; PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MERIT MEDICAL SYSTEMS INC. HERO®; PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER Back to Search Results
Catalog Number SUPERHERO/EU
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Hemorrhage/Bleeding (1888)
Event Date 11/20/2023
Event Type  Injury  
Event Description
The account alleges that during a venous outflow component (voc) graft placement on (b)(6) 2023, the graft was inserted into the patient's internal jugular [ij] vein.The clinical team failed to acquire hemostasis following insertion, so the voc was removed.Both physicians involved [ir physician and surgeon] are indeed experienced in voc insertion procedures.General anesthesia was used for this procedure.Balloon dilatation was used prior to sheath placement, and prior to the excessive blood loss event.Excessive bleeding was noted around the sheath area following placement.The interventional radiologist and surgeon both attempted to minimize the blood loss for approximately 3-4 hours.Additional ballooning techniques to control the blood loss were attempted under fluoroscopy.The patient was temporarily stable for a time but, further surgical intervention was necessary as the patient continued to hemorrhage.A head and neck surgeon was consulted and assisted with blood loss techniques.Blood transfusions were started during the procedure and continued post-procedure.On tue (b)(6) 2023, the patient required further cardiothoracic surgical intervention.The patient expired in the evening of (b)(6) 2023.The actual cause of death is unknown.There is no product malfunction alleged with relation to this event.
 
Manufacturer Narrative
The suspect device is not expected to return for evaluation.A follow up will be submitted when the evaluation is complete.
 
Manufacturer Narrative
The suspect device was not returned for evaluation.The complaint could not be confirmed.The root cause could not be determined.A search of the complaint database was performed and no similar complaints for this lot number were found.The device history record was reviewed, and no exception documents were found.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HERO®
Type of Device
PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER
Manufacturer (Section D)
MERIT MEDICAL SYSTEMS INC.
1600 merit parkway
south jordan UT 84095
Manufacturer (Section G)
MERIT MEDICAL SYSTEMS INC.
1600 merit parkway
south jordan UT 84095
Manufacturer Contact
bryson heaton
1600 merit parkway
south jordan, UT 84095
8012084662
MDR Report Key18212394
MDR Text Key329044420
Report Number1721504-2023-00088
Device Sequence Number1
Product Code DSY
UDI-Device Identifier00884450564325
UDI-Public00884450564325
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
K213845
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative,Distributor
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 11/20/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/27/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Catalogue NumberSUPERHERO/EU
Device Lot NumberH2740963
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received12/12/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/28/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
-
-